Amylyx Pharmaceuticals Inc (AMLX)
1.72
+0.04
(+2.38%)
USD |
NASDAQ |
May 31, 16:00
1.72
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Gross Profit (TTM): 261.44M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 261.44M |
December 31, 2023 | 355.34M |
September 30, 2023 | 275.32M |
June 30, 2023 | 178.02M |
Date | Value |
---|---|
March 31, 2023 | 85.38M |
December 31, 2022 | 19.24M |
September 30, 2022 | 0.173M |
June 30, 2022 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
Jun 2022
355.34M
Maximum
Dec 2023
146.86M
Average
131.70M
Median
Gross Profit (TTM) Benchmarks
iRhythm Technologies Inc | 343.64M |
Cassava Sciences Inc | -- |
Bristol-Myers Squibb Co | 34.48B |
Moderna Inc | 1.086B |
ACADIA Pharmaceuticals Inc | 750.88M |